Masimo is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, including medical devices and a wide array of sensors.

 
  • Your Partner in Health
  • The Coronavirus is a growing health emergency. At Masimo, we are committed to supporting the needs of the medical community—for the benefit of care teams and patients alike.
 
  • COVID-19 Solutions
  • A range of noninvasive monitoring and single-use solutions to support surge capacity management
 
  • Tetherless Pulse Oximetry with Radius PPG™
  • Enhance patient and clinician safety by continuously monitoring from a distance
 
 
  • Rad-67™ Spot-check Monitoring Pulse CO-Oximeter®
  • More Than a Conventional Pulse Oximeter

News & Media

 
  • March 25, 2020
  • Irvine, California
  • Masimo (NASDAQ: MASI), today announced the results of a recently published ten-year retrospective study in which researchers at Dartmouth-Hitchcock Medical Center investigated the impact of an integrated clinical surveillance monitoring system, usin […]
  • March 23, 2020
  • Irvine, California
  • Masimo (NASDAQ: MASI) today announced that, in response to current worldwide blood shortages driven by the coronavirus pandemic, it is making rainbow® licenses available for no additional charge to hospitals where rainbow®-ready devices are already i […]
  • March 20, 2020
  • Masimo (NASDAQ: MASI), and University Hospitals (UH), one of the largest health systems in Northeast Ohio, today jointly announced Masimo SafetyNet™, an innovative, economically scalable patient management system designed to help clinicians care for […]

Discover More at Masimo

 

Masimo Personal Health

 

MightySat is for people who want to improve their health, wellness, or fitness by providing key measurements that are more accurate & not available on other health and wellness devices. […]

Patient Safety Movement

 

The Patient Safety Movement Foundation believes reaching ZERO preventable deaths in hospitals by 2020 (0X2020™) is not only the right goal, but an attainable one with the […]

2017 Masimo Annual Report

 

2017 Masimo Annual Report - Automating Care. Reflecting on the Past and Defining the Future. […]

Next Generation SedLine is not licensed for sale in Canada.

Caution: Federal (USA) law restricts this device to sale by or on the order of a physician. See instructions for use for full prescribing information, including indications, contraindications, warnings, and precautions.